References
Capri S, Ageno W, Imberti D et al (2010) Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis. Intern Emerg Med 5(1):33–40
Kennedy I (2009) Appraising the value of innovation and other benefits. A short study for NICE. Report commissioned by the UK DoH
Drummond M, Griffin A, Tarricone R (2009) Economic evaluation for devices and drugs—same or different? Value Health 12(4):402–406
Mauskopf JA, Sullivan SD, Annemans L et al (2007) Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices—budget impact analysis. Value Health 10(5):336–347
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarricone, R. Pharmaco-economics and decision making in health care. The case of “extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis”. Intern Emerg Med 6, 581–582 (2011). https://doi.org/10.1007/s11739-011-0651-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-011-0651-2